Sun Pharma stock on Friday corrected sharply after a new whistle-blower complaint was sent to SEBI against the company.

The year 2018 was very volatile for large-cap stocks. The S&P BSE Large-cap index has struggled in the last one year and currently, it has settled at the same level where it was one-year back at 4,223. It had touched a 52-week high of 4,573.03 on September 3, 2018, and 52-week low of 3,867.52 on October 26, 2018.

Gold prices have formed a contracting triangle kind of pattern and the volume and price movement are getting squeezed.

Reliance Industries posted solid Q3FY19 show and became the first Indian private firm to cross Rs. 10,000 crore quarterly profit mark, on account of strong performance by petrochemicals, retail and digital services business.

Shares of the pharma major Sun Pharmaceutical tanked by 10 per cent in early trade on Friday. Read on to find the MF schemes that are most impacted by this fall.

Global chemicals major BASF and Adani Group are exploring acrylics value chain business opportunities out of Mundra, Gujarat. The two companies are planning to jointly produce several chemicals for the domestic industry.

Following stocks are close to their 52-week low as at 12.45 p.m. on January 18, 2019.

The markets on January 18, 2019 opened up. BSE Sensex is trading at 36,272.17, down by 101.91 points and the Nifty is trading at 10,874.00, down by 31.20 points. 

 This expansion would lead the company to capture the Delhi NCR market, which is the largest milk market of the country worth Rs. 11,000 crore. The company has witnessed 28 per cent CAGR growth in the revenue from ‘Pride of Cows’ over FY13-18.

HUL witnessed strong volume-driven growth in Q3FY19. The domestic consumer segment registered a growth of 13 per cent while the underlying volume growth stood at 10 per cent.